Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryoneurolysis in Anterior Cruciate Ligament Reconstruction (ACLR)

NCT: NCT07731178 · NOT_YET_RECRUITING

NCT IDNCT07731178
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2028-08
SponsorNYU Langone Health (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research study is to assess whether cryoneurolysis will help control pain after ACLR surgery and decrease the need of opioid medications. The primary objective is to compare postoperative functional recovery between Iovera and sham arms at 1 month after ACLR.

Frequently Asked Questions

What is Cryoneurolysis in Anterior Cruciate Ligament Reconstruction (ACLR)?

Cryoneurolysis in Anterior Cruciate Ligament Reconstruction (ACLR) is a clinical trial registered under NCT07731178. Current status: NOT_YET_RECRUITING.

What is the status of NCT07731178?

The current status of NCT07731178 (Cryoneurolysis in Anterior Cruciate Ligament Reconstruction (ACLR)) is: NOT_YET_RECRUITING.

When did Cryoneurolysis in Anterior Cruciate Ligament Reconstruction (ACLR) start?

Cryoneurolysis in Anterior Cruciate Ligament Reconstruction (ACLR) started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑